专利检索 ap:("University of Guelph" OR "Ottawa Hospital Research Institute") AND inv:"Martin Hubert Kang" 第 1 页

1.

发明授权
Adeno-associated virus particle with mutated capsid and methods of use thereof 有权

公开(公告)号：US10806802B2

公开(公告)日：2020-10-20

申请号：US16251119

申请日：2019-01-18

申请人： University of Guelph , Ottawa Hospital Research Institute

发明人： Sarah Wootton , Laura van Lieshout , Bernard Claude Frank Thebaud , Martin Hubert Kang

IPC分类号： C12N15/00 , C12N15/86 , A61K48/00 , A61K9/12 , A61P31/14 , A61K9/00

摘要： A recombinant adeno-associated virus (rAAV) particle with a mutated capsid protein is provided. In particular, the present disclosure provides methods of delivering a therapeutic agent to a muscle, airway, liver, central nervous system, retina or lung cell in a subject, and methods of treating or preventing infectious, acquired or genetic disease, with said rAAV particle.

2.

发明申请
ADENO-ASSOCIATED VIRUS PARTICLE WITH MUTATED CAPSID AND METHODS OF USE THEREOF 审中-公开

公开(公告)号：US20190216949A1

公开(公告)日：2019-07-18

申请号：US16251119

申请日：2019-01-18

申请人： University of Guelph , Ottawa Hospital Research Institute

发明人： Sarah Wootton , Laura van Lieshout , Bernard Claude Frank Thebaud , Martin Hubert Kang

IPC分类号： A61K48/00 , A61K9/00 , A61K9/12 , A61P31/14

摘要： A recombinant adeno-associated virus (rAAV) particle with a mutated capsid protein is provided. In particular, the present disclosure provides methods of delivering a therapeutic agent to a muscle, airway, liver, central nervous system, retina or lung cell in a subject, and methods of treating or preventing infectious, acquired or genetic disease, with said rAAV particle.